Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 83774-102

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 83774-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pilnova Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Azacitidine (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 01)

Chemical structure of azacitidine showing its molecular framework with nitrogen-containing rings and hydroxyl groups, consistent with the active ingredient azacitidine for injection.*

FDA Label Image

Kaplan-meier Curve Of Time To Death From Any Cause: (intent-to-treat Population) (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 02)

A Kaplan-Meier survival curve chart comparing the proportion surviving over time (months from randomization) between two groups labeled AZA and CCR. The chart includes a table showing the number at risk at various time points and statistical data including a log-rank p-value of 0.0001 and hazard ratio (HR) of 0.58 with 95% confidence interval (CI) 0.43-0.77. Death counts are also provided for AZA and CCR groups.*

FDA Label Image

Azacitidine For Injection 100mg/vial, Vial Label (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 03)

Label for Azacitidine for Injection 100 mg/vial, a lyophilized powder for solution used via subcutaneous and intravenous routes. The single-dose vial label includes storage instructions, manufacturer Shilpa Medicare Limited in India, and distributor Pilnova Pharma Inc in New Jersey. The label displays lot, expiration, barcode, and drug handling guidelines.*

FDA Label Image

Azacitidine For Injection 100mg/vial Carton Label (E1ef6b99 Ee6e 4387 B3d2 E74e35af5661 04)

Packaging label for Azacitidine for Injection 100 mg/vial, a lyophilized powder for solution. The label specifies use for subcutaneous and intravenous administration, indicates one single-dose vial per package, and states Rx only. Manufactured by Shilpa Medicare Limited, India, and distributed by Pilnova Pharma Inc, Hillsborough, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.